| Parameter | Quetiapine | Olanzapine | Risperidone | Aripiprazole | Ziprasidone |
---|---|---|---|---|---|---|
(n = 62) | (n = 24) | (n = 51) | (n = 44) | (n = 27) | ||
Physical component summary | Baseline (SD) | 45.8 (10.3) | 50.1 (9.5) | 48.1 (8.5) | 46.9 (11.0) | 48.6 (10.5) |
LOCF (SD) | 44.1 (9.6) | 51.0 (8.8) | 50.4 (8.8) | 46.0 (10.1) | 47.0 (9.9) | |
Mean change (SD) | -1.3 (9.0) | 1.3 (6.0) | 2.4 (9.1) | -2.1 (7.9) | -0.4 (6.8) | |
p-value | 0.046 | 0.077 | 0.124 | 0.190 | 0.427 | |
Mental component summary | Baseline (SD) | 38.9 (10.9) | 43.8 (12.8) | 43.8 (10.9) | 42.2 (9.8) | 39.5 (10.0) |
LOCF (SD) | 44.2 (10.9) | 44.3 (15.7) | 46.2 (10.0) | 45.1 (9.2) | 44.9 (10.4) | |
Mean change (SD) | 4.2 (11.3) | 0.0 (15.0) | 2.6 (10.8) | 4.7 (10.4) | 5.6 (10.2) | |
p-value | 0.029 | 0.834 | 0.298 | 0.002 | 0.129 |